6-methoxy-n-(3-sulfopropyl)quinolinium has been researched along with tyrosine in 1 studies
Studies (6-methoxy-n-(3-sulfopropyl)quinolinium) | Trials (6-methoxy-n-(3-sulfopropyl)quinolinium) | Recent Studies (post-2010) (6-methoxy-n-(3-sulfopropyl)quinolinium) | Studies (tyrosine) | Trials (tyrosine) | Recent Studies (post-2010) (tyrosine) |
---|---|---|---|---|---|
63 | 0 | 2 | 44,273 | 846 | 8,225 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bebok, Z; Clancy, JP; Collawn, JF; Jurkuvenaite, A; Kirk, KL; Li, Y; Nowotarski, K; Sorscher, EJ; Varga, K | 1 |
1 other study(ies) available for 6-methoxy-n-(3-sulfopropyl)quinolinium and tyrosine
Article | Year |
---|---|
Mutations in the amino terminus of the cystic fibrosis transmembrane conductance regulator enhance endocytosis.
Topics: Animals; Arginine; Biotinylation; Cell Membrane; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Cystic Fibrosis Transmembrane Conductance Regulator; Endocytosis; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Immunoprecipitation; Models, Biological; Mutation; Patch-Clamp Techniques; Phenotype; Polymerase Chain Reaction; Protein Structure, Tertiary; Quinolinium Compounds; Transfection; Tyrosine | 2006 |